CAR-TCR Summit Coverage – Track Latest Insights on Novel CAR-T Cell Therapies for B-Cell Malignancies | DelveInsight
A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...
Hosted on MSN19h
NICE green lights two blood cancer therapies for NHS use
BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
The Irish connection to Banksy’s Crude Oil (Vettriano), now expected to fetch as much as €6m at auction
Image of the week this week comes courtesy of Banksy, whose painting Crude Oil (Vettriano) is set to go to auction at Sotheby’s in London early next month, having been put on the block by the man who ...
News Medical14m
Development of lymphoma following CAR-T cell therapy
Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.